510(k) Report

FDA product code · Immunology

System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer

NIGClass II21 CFR 866.6010510(k) required12 decisions since 20028 recalls

12 FDA decisions since 2002. 510(k) reviews decided 2021–2025 took a median of 75 days (half between 75 and 75). 8 recalls name this code, 0 of them Class I. The most-cited predicate is K020566, named by 5 later devices.

An in vitro diagnostic test for the quantitative measurement of the CA 19-9 tumor associated antigen in human serum or plasma. The test is intended as an aid in the management of patients with confirmed pancreatic cancer and serial monitoring of their response to therapy and disease progression. The test should only be used in patients with serum and plasma CA 19-9 values above the cut-off at the time of diagnosis…

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, immunology panel

Twenty years of NIG at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · NIG

1in 2023

2011: 12019: 12020: 12023: 12026 (partial year): 1
2007high 1 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NIG

Too few NIG 510(k)s in any year since 2007 to give a median.

Recalls per year · NIG

2in 2016

2010: 12011: 12012: 12016: 2
2007high 2 (2016) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NIG

98in 2025

2007: 62008: 92009: 112010: 122011: 82012: 1,7852013: 1822014: 1172015: 292016: 692017: 982018: 582019: 1352020: 932021: 692022: 832023: 1292024: 1212025: 98
2007high 1,785 (2012) · low 6 (2007)2025

MAUDE reports naming product code NIG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—06
20080—09
20090—011
20100—112
20111—18
20120—11,785
20130—0182
20140—0117
20150—029
20160—269
20170—098
20180—058
20191—0135
20201—093
20210—069
20220—083
20231—0129
20240—0121
20250—098
20261—0—
FIG. 1 — NIG by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in NIG? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 866.6010.